Stoptober, an event organized by the National Health Service (NHS) in the UK, is a campaign that encourages smokers to quit smoking in October, with the ultimate goal of helping them quit for good. The campaign provides a range of advice to those looking to quit smoking, strongly recommending a combination of behavioral support and the use of nicotine replacement therapy (NRT), including electronic cigarette products.
As part of its annual activities, York School has launched a campaign aimed at tackling the issue of vaping and smoking among young people in the area. Recent data revealed that nearly one-fifth of high school students in the city have used e-cigarettes. To address this, free patches, gum, and other NRT products are being provided to anyone aged between 12 and 17 who wishes to quit smoking or vaping.
Daniel Furniss, the assistant principal of Archbishop Holgate's School, expressed concern about the ease with which students are obtaining these products. "I know that many schools, including ours, are educating students about the dangers of using e-cigarettes and smoking. However, the convenience of purchasing e-cigarettes and their packaging does not solve this problem. We urge all students in the city to take advantage of this free support and encourage parents and caregivers to talk to their children to help raise awareness about the risks and dangers to their health.
Stoptober campaign encourages the use of e-cigarettes as a method to quit smoking.
In recent years, e-cigarettes have become one of the recommended adult alternative therapies during Stoptober. In fact, they have consistently been the most commonly used smoking cessation tool. Data collected from multiple smoking surveys indicate that these products are the favored smoking cessation aid among smokers because they mimic the act of smoking, making the transition from smoking to non-smoking easier.
Furthermore, a guidance released last year by the Medicines and Healthcare products Regulatory Agency (MHRA) stated that any approved electronic cigarette product will be made available by prescription to physicians. "Whether it's our newly launched COVID-19 vaccine or our innovative public health measures to reduce people's risk of serious illness, this country remains a global leader in the healthcare field," said former Health Secretary Sajid Javid at the time.
Statement:
This article is compiled from third-party information and is intended for industry discussion and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The compilation of this article is only for industry research and exchange.
Due to limitations in the translator's proficiency, the translated article may not fully express the same meaning as the original. Please refer to the original text for accuracy.
For any domestic, Hong Kong, Macau, Taiwan, or international issues, 2FIRSTS completely aligns with the Chinese government's stance and statements.
The compilation of information is the property of the original media and author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
